Uncontrolled sclerosis can functionally incapacitate any organ system, yet little is known about its phatophysiology(s). Using as a model the cutaneous sclerosis seen in murine graft-vs-host disease (GVHD), the proposal will examine in vitro several cellular interactions, as a first step toward a better understanding of the in vivo events that eventuate in collagen accumulation. We will use two murine chimeras: a chimera that spontaneously develops sclerosis during the second phase of its GVHD; and a chimera that normally doesn't develop sclerosis during GVHD, but that does sclerose selectively in ultraviolet light-exposed skin. We will measure collagen synthesis in fibroblast cultures, under conditions that should begin to clarify what cellular interactions are important. Future work will be centered on more precisely identifying the mediators of sclerosis and on designing drug therapies appropriate for each stage of the pathogenetic process.
| Steen, V D; Follansbee, W P; Conte, C G et al. (1996) Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum 39:677-81 |
| Steen, V D; Engel, E E; Charley, M R et al. (1996) Soluble serum interleukin 2 receptors in patients with systemic sclerosis. J Rheumatol 23:646-9 |
| Charley, M R; Mikhael, A; Hackett, J et al. (1988) Mechanism of anti-asialo GM1 prevention of graft-vs-host disease: identification of allo-antigen activated T cells. J Invest Dermatol 91:202-6 |
| Thiele, D L; Charley, M R; Calomeni, J A et al. (1987) Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells. J Immunol 138:51-7 |
